KARA FLORES: Open Payments
NPI 1881024073 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$630 in 20 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $561 · 2025 $630
Food & beverage: $630
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $257 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $250 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Boston Scientific Corporation | 1 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| SCPHARMACEUTICALS INC. | 1 | $15 |
Products named: REPATHA, LifeVest, LOKELMA, WATCHMAN FLX, JARDIANCE, FUROSCIX.
Industry payments across TX — which companies pay providers there.
